Vanguard Group’s Edesa Biotech EDSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32K | Hold |
15,864
| – | – | ﹤0.01% | 4222 |
|
|
2025
Q1 | $38.7K | Hold |
15,864
| – | – | ﹤0.01% | 4209 |
|
|
2024
Q4 | $27K | Hold |
15,864
| – | – | ﹤0.01% | 4245 |
|
|
2024
Q3 | $70.6K | Hold |
15,864
| – | – | ﹤0.01% | 4225 |
|
|
2024
Q2 | $67.9K | Hold |
15,864
| – | – | ﹤0.01% | 4265 |
|
|
2024
Q1 | $66.5K | Sell |
15,864
-481
| -3% | -$2.02K | ﹤0.01% | 4282 |
|
|
2023
Q4 | $74.7K | Sell |
16,345
-94,517
| -85% | -$432K | ﹤0.01% | 4338 |
|
|
2023
Q3 | $70.1K | Sell |
110,862
-20
| -0% | -$13 | ﹤0.01% | 4377 |
|
|
2023
Q2 | $89.9K | Hold |
110,882
| – | – | ﹤0.01% | 4401 |
|
|
2023
Q1 | $101K | Hold |
110,882
| – | – | ﹤0.01% | 4404 |
|
|
2022
Q4 | $240K | Buy |
110,882
+169
| +0.2% | +$365 | ﹤0.01% | 4273 |
|
|
2022
Q3 | $102K | Hold |
110,713
| – | – | ﹤0.01% | 4491 |
|
|
2022
Q2 | $178K | Hold |
110,713
| – | – | ﹤0.01% | 4484 |
|
|
2022
Q1 | $329K | Hold |
110,713
| – | – | ﹤0.01% | 4459 |
|
|
2021
Q4 | $623K | Sell |
110,713
-518
| -0.5% | -$2.92K | ﹤0.01% | 4383 |
|
|
2021
Q3 | $821K | Buy |
111,231
+2,073
| +2% | +$15.3K | ﹤0.01% | 4290 |
|
|
2021
Q2 | $576K | Buy |
109,158
+51,369
| +89% | +$271K | ﹤0.01% | 4247 |
|
|
2021
Q1 | $312K | Buy |
57,789
+38,820
| +205% | +$210K | ﹤0.01% | 4203 |
|
|
2020
Q4 | $81K | Buy |
18,969
+7,800
| +70% | +$33.3K | ﹤0.01% | 4155 |
|
|
2020
Q3 | $90K | Buy |
+11,169
| New | +$90K | ﹤0.01% | 4026 |
|